About
Hoth Therapeutics Inc (NASDAQ:HOTH) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 14 2026
Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide
Apr 2 2026
Hoth Therapeutics Announces Closing of $2.0 Million Registered Direct Offering
Apr 1 2026
Hoth Therapeutics Announces $2.0 Million Registered Direct Offering
Mar 31 2026
Hoth Therapeutics Announces Issuance of Chinese Patent for Cancer Cell-Targeting Technology
Mar 26 2026
Hoth Therapeutics Deploys OpenClaw™ AI Platform to Accelerate Drug Discovery
Financials
Revenue
$0
Market Cap
$9.41 M
EPS
-0.90
Translate